VSP Vision has released The Future of Oculomics, the latest installment in its Futurist Report series from the VSP Global Innovation Center. The new report explores the growing field of oculomics, the study of the eye’s connection to overall health, and its potential to strengthen the role of eye care within the larger health care system.

Oculomics examines how ophthalmic biomarkers visible in the eye can provide insights into systemic health and various disease states. According to VSP Vision, recent advancements in artificial intelligence, imaging technologies, and data analysis are expanding the possibilities for eyecare providers to detect and monitor health conditions beyond traditional eye health.

“The eye has long served as a window into full-body health. During a comprehensive eye exam, an optometrist can detect signs of more than 270 chronic conditions and diseases,” says Ruth Yomtoubian, vice president and head of the VSP Global Innovation Center. “Thanks to recent advancements in artificial intelligence, imaging technologies, and big data, the role of the eye and eye doctors in overall health is becoming even more significant.” 

The interactive digital report highlights several trends and findings:

• Although 87% of ECPs surveyed said they are unfamiliar with the term "oculomics," more than half (57%) reported they already provide health insights beyond eye health during exams. Additionally, 70% agreed that doing so could meaningfully enhance patient care.
• The report notes that patients are increasingly open to receiving broader health insights from their optometrists. In a survey of VSP Vision Care members, 92% agreed that eye exams can offer valuable health information beyond vision, and 82% said they were comfortable receiving those insights from their eye doctor.
• A growing number of early-stage companies are working to advance oculomics. The report highlights 15 startups leveraging AI-based diagnostic tools, handheld imaging devices, and wearable technologies.

As the field of oculomics evolves, the report suggests that further development of foundational technologies, regulatory pathways, and clinical referral networks will be needed to help integrate these innovations into routine care.

“Oculomics is an emerging field that is still developing,” says Yomtoubian. “As a leader in health-focused vision care, VSP is excited to explore the potential that oculomics offers for the future of eye care and overall healthcare.”